Market Overview

Japan Procedure Numbers for Interventional Cardiology 2018 (MedPro Edition) -


The "Japan
Procedure Numbers for Interventional Cardiology 2018 - MedPro"

report has been added to's

Procedure volumes have historically been both over reported and over
prescribed. In recent years over-stenting has been scrutinized heavily,
with multiple studies estimating that approximately 30% of stenting is
unnecessary. This has resulted in a significant decrease over the last
few years in not only the number of stents used per angioplasty
procedure, but the overall number of angioplasty procedures.

Studies have shown that coronary artery bypass graft procedures (CABG)
are as effective, or slightly more effective, than stenting procedures
at improving patient outcomes over the long term. However, stenting
procedures (angioplasties) are associated with faster patient recovery
times and have lower costs than CABG procedures.

In the past several years, stenting practices have declined sufficiently
to the point where excess stenting have become much less pervasive so
procedure number growth has resumed.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Disease Overview

2.1 Basic Anatomy

2.2 Disease Treatments And Diagnostics

2.2.1 General Diagnostics

2.2.2 Coronary Artery Disease (Cad)

2.2.3 Myocardial Infarction (Mi)

2.2.4 Angina Pectoris

2.3 Patient Demographics

2.3.1 General Statistics

3. Procedure Numbers

3.1 Angiography Procedures

3.2 Anglioplasty/Pci Procedures

3.3 Catheterization Procedures

Companies Mentioned

  • Abbott
  • Boston Scientific
  • Terumo
  • Medtronic
  • Philips Volcano
  • Goodman Co.
  • Cardinal Health
  • Nipro/InfraReDx
  • Asahi
  • B. Braun
  • Biosensors International Group Ltd.
  • Biotronik
  • C.R. Bard
  • Cardiovascular Systems Inc.
  • Cook Medical
  • Merit Medical
  • Olympus
  • Opsens
  • Stentys
  • Straub Medical
  • Teleflex
  • W. L. Gore

For more information about this report visit

View Comments and Join the Discussion!